Leading Forensic Laboratories Participate In Independent Validation Of The GE Healthcare Life Sciences And Netbio Rapid DNA System
5/7/2014 10:17:12 AM
CHALFONT ST. GILES, England & WALTHAM, Mass.--(BUSINESS WIRE)--GE Healthcare Life Sciences, (NYSE: GE), and NetBio named today several of the laboratories participating in the recently announced comprehensive developmental validation of DNAscan™ Rapid DNA Analysis™ System. Leading international and US accredited NDIS participating forensic laboratories are independently evaluating the overall system from “swab-in to profile-out”, including the on-board Expert System software which uses automated data interpretation to eliminate the need for human review.
Help employers find you! Check out all the jobs and post your resume.
comments powered by